Olink is excited to attend BSI Congress 2026 in Glasgow. Join us to hear UCL researchers share how Olink proteomics is advancing autoimmune disease research, with a focus on blood-based biomarker discovery in rheumatoid arthritis and giant cell arteritis, including validation, disease subtyping, and potential paths to clinical translation. We look forward to connecting with you and celebrating the British Society for Immunology’s 70th anniversary.



